Chronic granulomatous disease
Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- presence of risk factors
- history of prior infections
- shortness of breath
- perianal pain
- flank pain
- red skin lesion
- abnormal chest examination
- rigors
- fever
- chronic lymphadenopathy
- poor growth
- joint pain
- facial pain
- chorioretinal lesions
- skin scarring
Outros fatores diagnósticos
- fatigue
- diarrhoea
- abdominal pain
- cough
- anorexia
- arthralgias
- nausea and vomiting
- bloody urine
- abnormal urinary flow
- hepatosplenomegaly
- family history of discoid lupus
- oral ulcer
- skin rash
Fatores de risco
- family history of CGD
- age <5 years
- male sex
- abnormally skewed X chromosome inactivation in X-linked carriers
- myeloperoxidase and FCgammaRIIIb polymorphisms
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- FBC
- ESR
- CRP
- faecal calprotectin
- CT chest
- CT or ultrasound for active infection
- whole body PET scan with F-18 fluorodeoxyglucose (FDG)
- MRI scan
- colonoscopy
- pulmonary function tests
- nitroblue tetrazolium (NBT) test
- dihydrorhodamine (DHR) 123 test
Investigações a serem consideradas
- genetic sequencing for genes encoding NADPH oxidase components
- Western blotting
- flow cytometric analysis of individual NADPH oxidase components
Algoritmo de tratamento
active non-life-threatening infection: on first presentation
active life-threatening infection: on first presentation
following initial empirical treatment
following resolution of acute episode
Colaboradores
Autores
David Lowe, MA, MB Bchir, PhD, FRCP
Consultant Clinical Immunologist
The Royal Free Hospital
London
UK
Declarações
DL has received personal fees from Gilead for an educational video and from Merck for a roundtable discussion. He has received speaker fees from Biotest, Takeda, and Astra-Zeneca and support to attend a conference from Octapharma. DL also holds research grants from NIHR, MRC, LifeArc, GSK, and Bristol Myers Squibb and has received consultancy fees from GSK paid to his institution.
Выражение благодарностей
Dr David Lowe would like to gratefully acknowledge Dr Adrian Thrasher, Dr Rebecca A. Marsh, and Dr Jack J. Bleesing, previous contributors to this topic. AT is an author of a number of references cited in this topic. RAM and JJB declare that they have no competing interests. Dr Rebecca A. Marsh and Dr Jack J. Bleesing wish to thank Dan Marmer, Carrie Koenig, and the Cincinnati Children's Hospital Clinical Diagnostic Immunology Lab. They also wish to thank Steven M. Holland, MD, Thomas Fleisher, MD, and Anthony Segal, MD, PhD, for helpful correspondence.
Рецензенты
Niraj C. Patel, MD, MS
Associate Professor of Pediatrics
Duke University
Durham
NC
Раскрытие информации
NCP is on the Speakers Bureau for Amgen.
Andrew Gennery, MD
Reader in Paediatric Immunology & HSCT
Institute of Cellular Medicine
Medical School
Newcastle University
Newcastle-upon-Tyne
UK
Раскрытие информации
AG is an author of a reference cited in this topic. AG declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Список литературы
Основные статьи
Thomsen IP, Smith MA, Holland SM, et al. A comprehensive approach to the management of children and adults with chronic granulomatous disease. J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1082-8. Аннотация
Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015 Nov;136(5):1186-205.e1-78.Полный текст Аннотация
Статьи, указанные как источники
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Отличия
- leukocyte adhesion deficiency type I
- glucose-6-phosphate dehydrogenase deficiency
- myeloperoxidase deficiency
Больше ОтличияРекомендации
- Chronic granulomatous disorder: a guide for medical professionals
- Practice parameter for the diagnosis and management of primary immunodeficiency
Больше Рекомендации
Войдите в учетную запись или оформите подписку, чтобы получить полноценный доступ к BMJ Best Practice
Использование этого контента попадает под действие нашего заявления об отказе от ответственности